Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
Items 501–600 of 1,000
Chen, Y., & Lan, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451957 · Cited by 25
Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?
Calonge, N., Petitti, D. B., & Lin, K. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-3-200902030-00020 · Cited by 17
Rethinking 30-day mortality risk after radical prostatectomy
Alibhai, S. M. H., Leach, M., TOMLINSON, G. A., Krahn, M. D., Fleshner, N. E., & Naglie, G. (2006) · Urology · doi:10.1016/j.urology.2006.06.016 · Cited by 17
Hajili, T., Ohlmann, C., Linxweiler, J., Niklas, C., Janssen, M. W. W., Siemer, S., Stöeckle, M., & Saar, M. (2018) · British Journal of Urology · doi:10.1111/bju.14393 · Cited by 17
Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
Hudson, S. V., Ohman‐Strickland, P., Ferrante, J. M., Lu‐Yao, G. L., Orzano, A. J., & Crabtree, B. F. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.03.080136 · Cited by 17
on behalf of the ProtecT Study Group, Metcalfe, C. D., Tilling, K. M., Davis, M., Lane, J. A., Martin, R. M., Kynaston, H., Powell, P. H., Neal, D. E., Hamdy, F. C., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605181 · Cited by 17
Sphincter Lesions After Radical Prostatectomy—Evaluation and Classification
Gerullis, H., Quast, S., Eimer, C., Bagner, J., & Otto, T. (2011) · Journal of Endourology · doi:10.1089/end.2010.0581 · Cited by 16
Xylinas, E. N., Ploussard, G., Paul, A., Gillion, N., Vordos, D., Hoznek, A., TAILLE, A. D. L., Abbou, C. C., & Salomon, L. (2009) · The French Journal of Urology · doi:10.1016/j.purol.2009.08.037 · Cited by 16
Racial disparities and considerations for active surveillance of prostate cancer
Jiang, S., Narayan, V. M., & Warlick, C. A. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2017.09.11 · Cited by 16
Morgan Rouprêt, A., Hupertan, V., Compérat, É., Drouin, S., Phé, V., Xylinas, E. N., Demanse, D., Sibony, M., Richard, F., & Cussenot, O. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08473.x · Cited by 16
The face of high risk prostate cancer
Albertsen, P. C. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0254-3 · Cited by 16
Kuo, S., Hung, S., Wang, H., Chien, C.-C., Lu, C., Lin, H., Guo, H., Zou, J., Lin, C.-S., & Huang, C. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.100 · Cited by 20
Andrea Gallina, A., Briganti, A., Chun, F. K. ‐., Walz, J. C., Hutterer, G. C., Erbersdobler, A., Eichelberg, C., Schlomm, T., Ahyai, S., Perrotte, P., et al. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07147.x · Cited by 16
Berg, A. S., Lilleby, W. A., Bruland, Ø. S., & Fosså, S. D. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.031 · Cited by 17
Hisasue, S., Yanase, M., Shindo, T., Iwaki, H., Fukuta, F., Nishida, S., Muranaka, T., Miyamoto, S., Tsukamoto, T., & Takatsuka, K. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hym162 · Cited by 16
Jiang, P., Krockenberger, K., Vonthein, R., Tereszczuk, J., Schreiber, A., Liebau, S., Huttenlocher, S., Imhoff, D., Balermpas, P., Keller, C., et al. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0872-2 · Cited by 16
Prostate‐specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer
Punglia, R. S., Cullen, J. C., McLeod, D. G., Chen, Y., & D'Amico, A. V. (2007) · Cancer · doi:10.1002/cncr.23014 · Cited by 16
Substratification of high-risk localised prostate cancer treated by radical prostatectomy
Lodde, M., Harel, F., Lacombe, L., & Fradet, Y. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0252-5 · Cited by 15
Stratification of the aggressiveness of prostate cancer using pre‐biopsy multiparametric MRI (mpMRI)
Dwivedi, D. K., Kumar, R., Bora, G. S., Thulkar, S. P., Sharma, S., Gupta, S. D., & Jagannathan, N. R. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3452 · Cited by 15
Royce, P. L., Ooi, J. J. Y., Sothilingam, S., & Yao, H. H. (2020) · Prostate International · doi:10.1016/j.prnil.2019.12.002 · Cited by 15
Tilling, K. M., Garmo, H., Metcalfe, C. D., Holmberg, L., Hamdy, F. C., Neal, D. E., Adolfsson, J., Martin, R. M., Davis, M., Fall, K., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.023 · Cited by 15
Self-citationRobotic prostatectomy: facts or fiction?
Rocco, B. M. C., & Djavan, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60336-5 · Cited by 15
Joffe, R., & Klotz, L. H. (2007) · Urology · doi:10.1016/j.urology.2007.02.016 · Cited by 15
Résultats carcinologiques et fonctionnels de la prostatectomie totale laparoscopique robot-assistée
Drouin, S., Vaessen, C., Misraï, V., Ferhi, K., Bitker, M., Chartier-Kastler, E. J., Haertig, A., Richard, F., & Morgan Rouprêt, A. (2009) · The French Journal of Urology · doi:10.1016/j.purol.2008.11.009 · Cited by 15
Update on cryotherapy for localized prostate cancer
Ritch, C. R., & Katz, A. E. (2009) · Current Urology Reports · doi:10.1007/s11934-009-0035-6 · Cited by 15
Watchfully waiting: Medical intervention as an optimal investment decision
Meyer, E., & Rees, R. (2012) · Journal of Health Economics · doi:10.1016/j.jhealeco.2012.02.002 · Cited by 15
Penile Rehabilitation and Neuromodulation
Fácio, F. N., & Burnett, A. L. “. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.86 · Cited by 16
Radical Prostatectomy for High-risk Prostate Cancer
Karnes, R. J., Hatano, T., Blute, M. L., & Myers, R. P. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp130 · Cited by 15
Profile-specific survival estimates: Making reports of clinical trials more patient-relevant
Julien, M., & Hanley, J. A. (2008) · Clinical Trials · doi:10.1177/1740774508089511 · Cited by 15
Zhu, G., Liu, Z., Epstein, J. I., Davis, C., Christudass, C. S., Carter, H. B., Landis, P., Zhang, H., Chung, J., Hewitt, S. M., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0496 · Cited by 15
Minimally Invasive Approaches to Localized Prostate Carcinoma
Grubb, R. L., Vardi, I. Y., Bhayani, S. B., & Kibel, A. S. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.008 · Cited by 15
Best practice in primary care pathology: review 4: Figure 1
Smellie, W. S. A., Forth, J., Sundar, S., Kalu, E., McNulty, C. A. M., Sherriff, E., Watson, I. D., Croucher, C., Reynolds, T., & Carey, P. J. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035212 · Cited by 15
Li, C., Su, J. J. –., Wang, W.-Y., Lee, M. T., Wang, T.-Y., Jiang, K.-Y., Li, C.-F., Hsu, J., Chen, C.-K., Chen, M., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.10.024 · Cited by 14
The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer
Iversen, P., & Røder, M. A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.3.361 · Cited by 14
Surgical Management of Prostate Cancer
Wright, J. L., Izard, J., & Lin, D. W. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.08.010 · Cited by 14
Packer, J. R., Hirst, A. M., Droop, A., Adamson, R., Simms, M. S., Mann, V. M., Frame, F. M., O’Connell, D., & Maitland, N. J. (2019) · FEBS Letters · doi:10.1002/1873-3468.13589 · Cited by 14
Robotic or open radical prostatectomy after previous open surgery in the pelvic region
Mustafa, M., Pettaway, C. A., Davis, J. W., & Pisters, L. L. (2015) · Korean journal of urology · doi:10.4111/kju.2015.56.2.131 · Cited by 14
Yao, A., Iwamoto, H., Masago, T., Morizane, S., Honda, M., Sejima, T., & Takenaka, A. (2014) · Urologia Internationalis · doi:10.1159/000358175 · Cited by 14
Røder, M. A., Berg, K. D., Gruschy, L., Brasso, K., & Iversen, P. (2010) · Prostate Cancer · doi:10.1155/2011/236357 · Cited by 14
Froehner, M., Koch, R., Litz, R. J., Hakenberg, O. W., Oehlschlaeger, S., & Wirth, M. P. (2006) · Urology · doi:10.1016/j.urology.2006.03.050 · Cited by 14
Prostate Cancer Screening: What We Have Learned from the PLCO and ERSPC Trials
Rochelle, J. L., & Amling, C. L. (2010) · Current Urology Reports · doi:10.1007/s11934-010-0109-5 · Cited by 14
A National Survey of Medical Students’ Beliefs and Knowledge in Screening for Prostate Cancer
Marcella, S., Delnevo, C. D., & Coughlin, S. S. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0015-1 · Cited by 15
Petit, J. H., Chen, M., Loffredo, M. J., Sussman, B., Renshaw, A. A., & D'Amico, A. V. (2006) · Cancer · doi:10.1002/cncr.22243 · Cited by 15
Preperitoneal repair of inguinal hernia at open radical prostatectomy
Savetsky, I. L., Rabbani, F., Singh, K., & Brady, M. S. (2009) · Hernia · doi:10.1007/s10029-009-0507-0 · Cited by 14
Loeb, S., Roehl, K. A., Thaxton, C. S., & Catàlona, W. J. (2008) · Urology · doi:10.1016/j.urology.2007.11.009 · Cited by 14
Hammad, F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1414.032 · Cited by 14
The Politics of Prostate Cancer Screening
Kaffenberger, S. D., & Penson, D. F. (2014) · Urologic Clinics of North America · doi:10.1016/j.ucl.2014.01.004 · Cited by 13
Counseling patients about sexual health when considering post-prostatectomy radiation treatment
Wittmann, D. A., Montie, J. E., Hamstra, D. A., Sandler, H. M., & Wood, D. P. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.32 · Cited by 14
Fiorica, F., Berretta, M., Colosimo, C., Berretta, S., Ristagno, M., Palmucci, T., Palmucci, S., Lleshi, A., Ursino, S., Fisichella, R., et al. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.11.019 · Cited by 13
Prostatectomy Versus Observation for Localized Prostate Cancer: A Meta-Analysis
Luo, X., Yi, M., Hu, Q., & Yin, W. (2019) · Scandinavian Journal of Surgery · doi:10.1177/1457496919883962 · Cited by 13
Pearce, A. G., Newcomb, C. H., & Husain, S. M. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.592 · Cited by 13
An elusive tumor in a man who has evidence of prostate cancer metastasis
Boyer, B. P., & Boyer, M. J. (2009) · JAAPA · doi:10.1097/01720610-200908000-00007 · Cited by 13
Racial disparities in prostate cancer survival in a screened population: Reality versus artifact
Kaur, D., Ulloa‐Pérez, E., Gulati, R., & Etzioni, R. (2018) · Cancer · doi:10.1002/cncr.31253 · Cited by 13
Place de la surveillance active dans le cancer de la prostate : présentation du protocole français
Mottet, N., & Irani, J. (2008) · Progrès en Urologie - FMC · doi:10.1016/s1761-676x(08)70021-x · Cited by 13
Gianino, M. M., Galzerano, M., Minniti, D., Novi, C. D., Martin, B. S., Davini, O., & Barbaro, S. (2009) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309990043 · Cited by 13
Management of Prostate Cancer in the Older Man
Mohile, S. G., Lachs, M. S., & Dale, W. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.08.003 · Cited by 13
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Walsh, P. C. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000177581.65302.f3 · Cited by 13
Scholz, M. C., Lam, R. Y., Strum, S. B., Jennrich, R. I., Johnson, H. J., & Trilling, T. (2007) · Urology · doi:10.1016/j.urology.2007.04.015 · Cited by 13
Multimodal Approaches to High-Risk Prostate Cancer
Koupparis, A. J., & Gleave, M. E. (2010) · Current Oncology · doi:10.3747/co.v17i0.677 · Cited by 16
Johansson, B. H., Ridderheim, M., & Glimelius, B. L. G. (2005) · Acta Oncologica · doi:10.1080/02841860500355942 · Cited by 13
Bulletin de synthèse de veille 2005 Recommandations pour la pratique clinique
Soulie, M., Beuzeboc, P., Richaud, P. M., Villers, A. A., Kassab-Chahmi, D., & Bataillard, A. (2007) · The French Journal of Urology · doi:10.1016/s1166-7087(07)92296-4 · Cited by 13
Dehn, T. (2006) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588406x117133 · Cited by 13
Radical Prostatectomy in Austria: A Nationwide Analysis of 16,524 Cases
Mohamad, B. A.-A., Martin Marszalek, A., Brössner, C., Ponholzer, A., Wehrberger, C., Willinger, M., & Stephan Madersbacher, A. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.022 · Cited by 13
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Kibel, A. S. (2007) · Yearbook of Urology · doi:10.1016/s0084-4071(08)70131-3 · Cited by 13
Jeong, C. W., Han, J. H., Herlemann, A., Washington, S. L., Carroll, P. R., Carroll, P., & Cooperberg, M. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.220151 · Cited by 10
Kim, E. H., Vemana, G., Johnson, M. H., Vetter, J. M., Rensing, A. J., Strother, M. C., Fowler, K. J., & Andriole, G. L. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.09.004 · Cited by 12
Scholz, M. C., Lam, R. Y., Strum, S. B., LaBarba, D. J., Becker, L. K., Chang, P. J., Farhoumand, N., & Jennrich, R. I. (2011) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2011.07.002 · Cited by 14
Multigene panels in prostate cancer risk assessment: a systematic review
Little, J., Wilson, B. J., Carter, R., Walker, K., Santaguida, P. L., Tomiak, E. M., Beyene, J., Ali, M. U., & Raina, P. S. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.125 · Cited by 12
Hashimoto, T., Yoshioka, K., Horiguchi, Y., Inoue, R., Yoshio, O., Nakashima, J., & Tachibana, M. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.07.009 · Cited by 12
What Will the Emperor Say? Screening for Prostate Cancer as of 2008
Concato, J. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e31819765da · Cited by 12
Rodney, S., Shah, T. T., PATEL, H. R. H., & Arya, M. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.974565 · Cited by 12
Socioeconomic status and disparities in treatment patterns
Chu, D. I., & Freedland, S. J. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.121 · Cited by 12
Łuczyńska, E., Gasińska, A., Blecharz, P., Stelmach, A., Jereczek‐Fossa, B. A., & Reinfuss, M. (2014) · Polish Journal of Pathology · doi:10.5114/pjp.2014.45787 · Cited by 12
Evolving Recommendations on Prostate Cancer Screening
Brawley, O. W., Thompson, I. M., & Grönberg, H. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_157413 · Cited by 18
Skolarus, T. A., Metreger, T., Hwang, S., Kim, H. M., Grubb, R. L., Gingrich, J. R., & Hawley, S. T. (2017) · Trials · doi:10.1186/s13063-017-1925-4 · Cited by 12
Wiegel, T., Albers, P., Bartkowiak, D., Bussar-Maatz, R., Härter, M. C., Kristiansen, G., Martus, P., Wellek, S., Schmidberger, H., Grozinger, K., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03327-2 · Cited by 12
Nocera, L., Wenzel, M., Ruvolo, C. C., Würnschimmel, C., Tian, Z., Gandaglia, G., Fossati, N., Chun, F. K. ‐., Mirone, V., Graefen, M., et al. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.04.004 · Cited by 12
Lu‐Yao, G. L., Kim, S., Moore, D. F., Shih, W. J., Lin, Y., DiPaola, R. S., Shen, S., Zietman, A. L., & Yao, S.-L. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.30 · Cited by 12
Erdeljan, P., Brock, G. B., & Pautler, S. E. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02004.x · Cited by 12
Watchful waiting versus active surveillance: Appropriate patient selection
Dall’Era, M., & Kane, C. J. (2008) · Current Urology Reports · doi:10.1007/s11934-008-0037-9 · Cited by 12
Optical coherence tomography: the past, present and future
Goel, R. K., & Kaouk, J. H. (2007) · Journal of Robotic Surgery · doi:10.1007/s11701-007-0045-7 · Cited by 12
Mongiat-Artus, P., Peyromaure, M., Richaud, P. M., Droz, J., Rainfray, M., Jeandel, C., Rébillard, X., Moreau, J.-L., Davin, J., Salomon, L., et al. (2009) · The French Journal of Urology · doi:10.1016/j.purol.2009.02.008 · Cited by 12
Tagawa, S. T., Dorff, T. B., Rochanda, L., Ye, W., Boyle, S. F., Raghavan, D., Lieskovsky, G., Skinner, D. G., Quinn, D. I., & Liebman, H. A. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07780.x · Cited by 12
Prostate Brachytherapy in Men ≥75 Years of Age
Merrick, G. S., Wallner, K. E., Galbreath, R. W., Butler, W. M., Brammer, S. G., Allen, Z. A., & Adamovich, E. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.01.017 · Cited by 13
(1994) · CRC Press eBooks · doi:10.1201/9781439805497-17 · Cited by 12
Hammerer, P. G., Kattan, M. W., Mottet, N., & Prayer-Galetti, T. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06177.x · Cited by 12
Liu, J., Shi, H., Sartor, O. A., & Culbertson, R. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44144 · Cited by 11
Economic analysis of active surveillance for localized prostate cancer
Kim, S. I., Dall’Era, M., & Evans, C. P. (2012) · Current Opinion in Urology · doi:10.1097/mou.0b013e328351dd32 · Cited by 11
García‐Barreras, S., Rozet, F., Nunes‐Silva, I., Srougi, V., Sanchez‐Salas, R., Barret, É., Galiano, M., & Cathelineau, X. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1812-1 · Cited by 11
Shah, K. K., & Abaza, R. M. D. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10081.x · Cited by 11
Kench, J. G., Clouston, D. R., Delprado, W., Eade, T., Ellis, D. W., Horvath, L. G., Samaratunga, H., Stahl, J., Stapleton, A. M. F., Egevad, L., et al. (2011) · Pathology · doi:10.1097/pat.0b013e328348a6b3 · Cited by 11
The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in Perspective
Cheng, C. (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1395w · Cited by 12
Contemporary Management of Prostate Cancer
Cotter, K. J., Konety, B. R., & Ordoñez, M. (2016) · F1000Research · doi:10.12688/f1000research.7183.1 · Cited by 11
Wang, K., Sheets, N. C., Basak, R., & Chen, R. C. (2016) · Cancer · doi:10.1002/cncr.30154 · Cited by 11
Adam, A., Ras, R., Bhattu, A. S., Raman, A., & Perera, M. (2017) · Current Urology · doi:10.1159/000447191 · Cited by 11
Prostate cancer survivorship care in the Veterans Health Administration.
Skolarus, T. A., & Hawley, S. T. (2014) · PubMed · Cited by 11
Active Surveillance with Selective Delayed Intervention for Favorable Risk Prostate Cancer
Klotz, L. H., & Nam, R. K. (2006) · Seminars in Preventive and Alternative Medicine · doi:10.1016/j.spre.2006.01.002 · Cited by 11
Asimakopoulos, A. D., Annino, F., Colalillo, G., Gastón, R., Piéchaud, T., Mauriello, A., Anceschi, U., & Borri, F. (2023) · Current Oncology · doi:10.3390/curroncol30010082 · Cited by 13
Froehner, M., Koch, R., Litz, R. J., & Wirth, M. P. (2009) · Urology · doi:10.1016/j.urology.2008.09.084 · Cited by 11
The Effect of Age on Prostate Implantation Results
Peschel, R. E., Khan, A. M., Colberg, J. W., & Wilson, L. D. (2006) · The Cancer Journal · doi:10.1097/00130404-200607000-00009 · Cited by 11
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.